An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation
- PMID: 22678141
- DOI: 10.1038/jp.2012.71
An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation
Abstract
We provide an approach to the use of phototherapy and exchange transfusion in the management of hyperbilirubinemia in preterm infants of <35 weeks of gestation. Because there are limited data for evidence-based recommendations, these recommendations are, of necessity, consensus-based. The recommended treatment levels are based on operational thresholds for bilirubin levels and represent those levels beyond which it is assumed that treatment will likely do more good than harm. Long-term follow-up of a large population will be needed to evaluate whether or not these recommendations should be modified.
Comment in
-
Let there be light-but should there be less?J Perinatol. 2012 Sep;32(9):649-51. doi: 10.1038/jp.2012.80. J Perinatol. 2012. PMID: 22931960 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical